Organon (MEX:OGN) Scaled Net Operating Assets : 0.75 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Organon's operating assets for the quarter that ended in Sep. 2024 was MXN236,067 Mil. Organon's operating liabilities for the quarter that ended in Sep. 2024 was MXN69,113 Mil. Organon's Total Assets for the quarter that ended in Jun. 2024 was MXN222,663 Mil. Therefore, Organon's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.75.

Organon Scaled Net Operating Assets Historical Data

The historical data trend for Organon's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Scaled Net Operating Assets Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.68

0.70

0.65

0.64

Organon Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.71	0.71	0.66	0.75	0.75

Competitive Comparison of Organon's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, Organon's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Organon's Scaled Net Operating Assets falls into.

Organon Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Organon's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(192912.328	-	57169.268)	/	213578.68
=	0.64

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	204675.482	-	11763.154
=	192912.328

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	205863.68	-	148541.644	-	152.768
=	57169.268

Organon's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(236067.007	-	69112.953)	/	222662.532
=	0.75

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	251090.706	-	15023.699
=	236067.007

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	241383.388	-	172073.532	-	196.903
=	69112.953

Organon Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Organon's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (MEX:OGN) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

OGN:USA 1OGN:Italy 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.